Clinical Trials on Subject Hunger Response in New Zealand

Total 368 results

Eisai Co., Ltd.

Completed

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

Healthy Subjects

New Zealand
OrsoBio, Inc

Active, not recruiting

A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants

Healthy Subjects

New Zealand
EicOsis Human Health Inc.

Recruiting

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects

Healthy Subjects

New Zealand
Huabo Biopharm Co., Ltd.

Completed

A Study of Injection HB0017 in Adult Healthy Volunteers

Healthy Subjects

New Zealand
Derek Victor Byrne
University of Copenhagen; Danish Research Centre for Magnetic Resonance

Completed

The Omnibus Satiety Metric: Predicting Satiety in Humans Through Brain, Blood, and Subjective Data (OmniSaM)

Behavior | Hunger | Appetite | Satiation

Denmark
Celltrion

Completed

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Healthy Subjects

New Zealand
Alvotech Swiss AG
Iqvia Pty Ltd

Completed

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

Healthy Adult Subjects

New Zealand, United Kingdom
Waikato Hospital

Enrolling by invitation

A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger

Trigger Finger

New Zealand
Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

New Zealand
OrsoBio, Inc

Recruiting

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity

Obesity | Healthy Subjects

New Zealand
Hoffmann-La Roche

Completed

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Healthy Male Subjects

Australia, New Zealand
Future University in Egypt

Completed

Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

Healthy Subjects

Egypt
Brock University

Completed

Dairy Consumption During a High-intensity, High-volume Training Week in Young Athletes

Inflammatory Response | Sports Performance

Canada
Cosmo Technologies Ltd

Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Informational Intervention in Increasing Lactation Practices by African American Women

Pregnant | Healthy Subject

United States
University of Rochester

Completed

Assessment of Prototype Hand-Held Fundus Camera

Normal Subject Population

United States
University of British Columbia

Completed

Predicting Complications in Women With Toxaemia

Toxemia

United Kingdom, Canada, New Zealand
Rijnstate Hospital

Withdrawn

Post Implant Syndrome After EVAR and EVAS (INSPIRE Study)

Inflammatory Response | Abdominal Aortic Aneurysm

New Zealand, Netherlands, Spain, Germany, Poland
Australian and New Zealand Intensive Care Research...
Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaborators

Completed

The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial (VITAMINS)

Sepsis | Shock, Septic | Critically Ill | Vasoplegic Syndrome

Australia, New Zealand, Brazil
Roswell Park Cancer Institute
National Cancer Institute (NCI); University of Rochester

Recruiting

Consumer Assessment of Tobacco Flavor and Odor

Healthy Subject | Current Vaper

United States
Roswell Park Cancer Institute
National Institute on Drug Abuse (NIDA); National Cancer Institute (NCI)

Completed

Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers (ENDS)

Current Smoker | Healthy Subject | Cigarette Smoker

United States
Future University in Egypt

Completed

Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
University of Medicine and Dentistry of New Jersey

Completed

Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume

Peripheral Vascular Response

United States
Aerie Pharmaceuticals

Completed

A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers

Healthy Subjects

United States
New Mexico Cancer Care Alliance
Oxnard Foundation

Terminated

Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells

Healthy Subjects

United States
GlaxoSmithKline

Completed

GSK1349572 Drug Interaction With Tenofovir

Healthy Subjects

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects

Healthy Subjects

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects

Healthy Subjects

United States
Bausch Health Americas, Inc.

Completed

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

Healthy Subjects

United States
Pfizer

Completed

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Healthy Subjects

United States
Pfizer

Completed

A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961

Healthy Subjects

United States
Pfizer

Completed

First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects

Healthy Subjects

United States
ViiV Healthcare
Pfizer

Completed

THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC

Healthy Subjects

United States
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

Healthy Subjects

United States
GlaxoSmithKline

Withdrawn

A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

Healthy Subjects

United States
GlaxoSmithKline

Completed

A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype

Healthy Subjects

United States
GlaxoSmithKline
Shionogi

Completed

GSK1349572 Drug Interaction Study With Etravirine

Healthy Subjects

United States
GlaxoSmithKline

Completed

A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.

Healthy Subjects

United States
Yale University
American Heart Association

Completed

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Healthy Subjects

United States
Trinomab Biotech Co., Ltd.
TIGERMED AUSTRALIA PTY LIMITED

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults

Healthy Adult Subjects

Australia
Bausch Health Americas, Inc.

Completed

Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects

Healthy Adult Subjects

United States
Bausch Health Americas, Inc.

Completed

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

Healthy Adult Subjects

United States
Microbiotix, Inc.

Completed

Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers

Healthy Adult Subjects

United States
Bausch Health Americas, Inc.

Completed

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

Methadone-maintenance Subjects

United States
NYU Langone Health

Recruiting

taVNS on Pupillary Response and Perceptual Learning

Pupillary Response

United States
DSM Nutritional Products, Inc.

Completed

Photoallergic Potential of 6% Bemotrizinol

Photoallergic Response

United States
Pfizer

Completed

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

Healthy Subjects

United States
Halia Therapeutics, Inc.
TKL Research, Inc.

Completed

Study to Evaluate HT-6184 in Healthy Subjects

Normal Healthy Subjects

United States
Hospital for Special Surgery, New York

Completed

Steroids in Bilateral Total Knee Replacement

Postoperative Inflammatory Response

United States

Clinical Trials on Subject Hunger Response in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations